SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-08-008888
Filing Date
2008-08-07
Accepted
2008-08-07 14:48:43
Documents
5
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2187216z10-q.htm 10-Q 258588
2 EXHIBIT 31.1 a2187216zex-31_1.htm EX-31.1 8075
3 EXHIBIT 31.2 a2187216zex-31_2.htm EX-31.2 8083
4 EXHIBIT 32.1 a2187216zex-32_1.htm EX-32.1 4460
5 EXHIBIT 32.2 a2187216zex-32_2.htm EX-32.2 4464
  Complete submission text file 0001047469-08-008888.txt   285222
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16614 | Film No.: 08998061
SIC: 2835 In Vitro & In Vivo Diagnostic Substances